Why IMU is a multi multi bagger, page-16532

@Whatmighthavben

Enjoy your posts Wats and certainly appreciate the time spent on them but despise the crap you have to put up with when you’ve been an incredible source of information.

Agree that the employment of key people that can progressively input from day 1 is vital in any business. But I’ve got to ask when does a management team become top heavy and over burdened leading to failing productivity. Or more to the point, too many chiefs and not enough Indians.

Since 2021 we have seen the employment of many so-called experts joining the Imogene team all hyped up to take the company to another level. Bio experts, corporate deals experts, business operations experts you name it.
Seriously, I’m not seeing a lot for it and if anything judging by company announcements there seems be a lull in anything corporate or bio related. The only one busy seems to be PH for the wrong reasons IMO.

Yes Nick Ede is outstanding and has been for over a decade.

But as for this below list, I’m not so sure.

Mike Tonroe | Chief Financial Officer
John Byon | Senior VP Clinical Development
Monil Shah | Chief Business Officer
Dr Paul Woodard | Chief Medical Officer
Dr Bradley Glover | Chief Operating Officer
Dr Jens Eckstein | Non-Executive Director
Dr Lesley Russell | Non-Executive Director
Kim Drapkin | Non-Executive Director

All just my opinion.

Cheers.